Explorer les evidences

46,16 yearsThe mean age of 154 COVID-19 patients in Nigeria was 46.16 years with a standard deviation of 13.701.

NigeriaCOVID-19observé June to August 30, 2020publié 2020CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF COVID-19 PATIENTS IN LAGOS, NIGERIA: A DESCRIPeurope_pmcdocument de 3 observationsDOI 10.1101/2020.09.15.20195412

This study included the total population of patients with laboratory confirmed diagnosis of COVID-19 in the University of Benin Teaching Hospital, Edo State, Nigeria from March 31 to June 30, 2020.

NigeriaCOVID-19observé March 31 to June 30, 2020publié 2020West African journal of medicinePubMeddocument de 8 observations

12 daysThe median duration of hospital stay was 12 days.

NigeriaCOVID-19observé 2020publié 2020The Pan African medical journaleurope_pmcdocument de 9 observations

9 per_millionCase mortality rate (CMR) for COVID-19 in Lagos, Abuja and Edo was above 9 per million population.

NigeriaCOVID-19publié 2020The Pan African medical journalPubMeddocument de 6 observations

6,3 %SARS-CoV-2 prevalence was 6.3% among persons living with HIV in Kenya, Uganda, Tanzania, and Nigeria between 19 July 2022 and 1 March 2024.

Kenya · Nigeria · Ouganda · TanzanieCOVID-19observé 19 July 2022 to 1 March 2024publié 2025BMC infectious diseasesPubMeddocument de 8 observations

6,1 %Thirteen (6.1%) of 212 prepandemic samples from Nigeria tested positive on the Abbott Architect IgG assay.

NigeriaCOVID-19publié 2021Journal of clinical microbiologyPubMeddocument de 6 observations

65,8 %Among 73 participants with diabetes mellitus, 65.8% were willing to take the COVID-19 vaccine when it becomes available in their country.

NigeriaCOVID-19 · diabète (non précisé)observé March-May 2021publié 2022International journal of environmental research and public healthPubMeddocument de 12 observations

3,97 odds_ratioAfter multivariable adjustment, the odds of DM were 3.97 higher in those with a history of COVID-19 compared to controls.

NigeriaCOVID-19 · diabète (non précisé)publié 2024BMC public healthPubMeddocument de 10 observations

20,4 %Among 4439 respondents in Nigeria during the first wave of the COVID-19 pandemic, 907 (20.4%) decreased food intake.

NigeriaCOVID-19publié 2021International journal of environmental research and public healthPubMeddocument de 3 observations

19 %In a study of 32 COVID-19 patients in Nigeria, anosmia and ageusia were present in 19% of patients.

NigeriaCOVID-19HAL · Unilimdocument de 97 observations

34,5 %Among 252 people living with HIV in Federal Capital Territory, Nigeria, 87 (34.5%) had received at least one dose of a COVID-19 vaccine.

NigeriaCOVID-19publié 2025Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument de 3 observations

6,8 %Prevalence at first nasal swab of SARS-CoV-2 was 6.8% among participants in Kenya, Uganda, Tanzania, and Nigeria between 19 July 2022 and 1 March 2024.

Kenya · Nigeria · Ouganda · TanzanieCOVID-19observé 19 July 2022 to 1 March 2024publié 2025BMC infectious diseasesPubMeddocument de 8 observations

44 %In a study of 32 COVID-19 patients in Nigeria, dry cough was present in 44% of patients.

NigeriaCOVID-19HAL · Unilimdocument de 97 observations

21,9 %Mortality was 21.9% among RT-PCR-negative patients and 6.6% among RT-PCR-positive patients.

NigeriaCOVID-19observé 27 February 2020 to 30 September 2020publié 2021The Nigerian postgraduate medical journalPubMeddocument de 12 observations

88 %A third study reported an 88.0% reduction in surface contamination from wiping compared to a 15.1% reduction from spraying.

NigeriaCOVID-19publié 2025Journal of public health in Africaeurope_pmcdocument de 3 observations

8 %A review and meta-analysis study of COVID-19 patients in April 2020 revealed bacterial co-infections in 8% of critically ill patients.

NigeriaCOVID-19observé April 2020HAL · Unilimdocument de 63 observations

47 614 samplesA total of 47,614 remnant HIV viral load samples were tested for SARS-CoV-2 antibodies in Nigeria between April 2022 and January 2023.

NigeriaCOVID-19 · VIH/sidaobservé April 2022 to January 2023publié 2025International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 2 observations

2,3 %Cardiovascular disease prevalence was 2.3% among RT-PCR-negative patients and 0.9% among RT-PCR-positive patients.

NigeriaCOVID-19 · maladies cardiovasculairesobservé 27 February 2020 to 30 September 2020publié 2021The Nigerian postgraduate medical journalPubMeddocument de 12 observations

1,4 %SARS-CoV-2 positivity rate was 1.4% using IgG ELISA among 791 animals screened in Nigeria.

NigeriaCOVID-19publié 2023Viruseseurope_pmcdocument de 6 observationsDOI 10.3390/v15051187

1 254 deathsAs of December 2020, 1,254 deaths due to COVID-19 have been reported in Nigeria.

NigeriaCOVID-19observé December 2020HAL · Unilimdocument de 63 observations

0,004 p-valueThe frequency of acute kidney injury was significantly higher in COVID-19 patients with diabetes mellitus (p=0.004).

NigeriaCOVID-19 · diabète (non précisé)publié 2022West African journal of medicinePubMeddocument de 15 observations

20 %Studies have shown that bacterial infection rate in COVID-19 patients is less than 20%.

Nigeriabacterial infection · COVID-19HAL · Unilimdocument de 63 observations

7,55 relative_risk_ratioIn the adjusted multinomial logistic regression analysis, individuals with a history of COVID-19 exhibited significantly elevated risks for pre-diabetes (RRR = 7.55).

NigeriaCOVID-19 · pre-diabetespublié 2024BMC public healthPubMeddocument de 10 observations

0,016 p-valueThe frequency of multi-organ failure was significantly higher in COVID-19 patients with diabetes mellitus (p=0.016).

NigeriaCOVID-19 · diabète (non précisé)publié 2022West African journal of medicinePubMeddocument de 15 observations

96,1 %Among community health workers in selected States of Nigeria, 96.10% have a positive attitude towards COVID-19 prevention-protocols.

NigeriaCOVID-19publié 2022The Pan African medical journalPubMeddocument de 10 observations